4D Molecular Therapeutics Inc.
4DMT Highlights Robust and Durable Clinical Activity for 4D 150 and[...]
LABCORP PRICES $650,000,000 IN 4.350% SENIOR NOTES DUE 2030,[...]
11/10/2022 | Press release | Distributed by Public on 11/10/2022 05:11
Please select the service you want to use:
Copyright ©2006-2024 Public Technologies Inc. | Privacy Policy | Terms of Use | Contact